Trial
NCT01965730
Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Aortic Disease
Intervention
epsilon-aminocaproic acid (EACA)
Why stopped
the study was suspended due to shortage of the study drug (amicar).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-02